lobbying_activities: 2260510

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2260510	c80146bc-0b95-4f20-aa1c-62f6258d2aae	1T	BROWN RUDNICK LLP	287895	APOTEX CORPORATION	2019	first_quarter	HCR	Public Law 115-52, Section 808, relating to the Competitive Generic Therapy designation; President's FY19 budget proposal relating to generic drug 180-Day exclusivity	HOUSE OF REPRESENTATIVES,SENATE	50000		0	1	2019-02-05T14:05:01.903000-05:00